DE CESARIS, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 2.123
EU - Europa 1.528
AS - Asia 1.049
SA - Sud America 149
AF - Africa 24
OC - Oceania 14
Totale 4.887
Nazione #
US - Stati Uniti d'America 2.107
RU - Federazione Russa 613
CN - Cina 302
SG - Singapore 278
PL - Polonia 266
IT - Italia 239
HK - Hong Kong 211
BR - Brasile 126
IE - Irlanda 123
SE - Svezia 99
KR - Corea 97
VN - Vietnam 49
CH - Svizzera 46
DE - Germania 41
GB - Regno Unito 37
JO - Giordania 26
IN - India 24
FR - Francia 21
ID - Indonesia 20
FI - Finlandia 17
AU - Australia 14
NL - Olanda 10
AR - Argentina 9
CI - Costa d'Avorio 9
MX - Messico 8
BD - Bangladesh 7
TR - Turchia 7
ZA - Sudafrica 7
CA - Canada 6
IQ - Iraq 6
CO - Colombia 5
JP - Giappone 5
UA - Ucraina 4
BJ - Benin 3
EC - Ecuador 3
IL - Israele 3
KG - Kirghizistan 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
CL - Cile 2
EE - Estonia 2
ES - Italia 2
PE - Perù 2
PH - Filippine 2
TH - Thailandia 2
TN - Tunisia 2
UZ - Uzbekistan 2
BE - Belgio 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
HR - Croazia 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
NP - Nepal 1
PK - Pakistan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 4.887
Città #
Santa Clara 657
Warsaw 266
Ashburn 195
Singapore 193
Hong Kong 184
Fairfield 142
Dublin 114
Seoul 97
Beijing 79
Hefei 77
Woodbridge 73
Chandler 69
Cambridge 60
Seattle 56
Dearborn 50
Altamura 48
Florence 47
Houston 47
Lawrence 47
Bern 45
Wilmington 44
Buffalo 42
Los Angeles 38
Chicago 35
Moscow 35
Princeton 26
Munich 24
Ho Chi Minh City 19
Shanghai 19
Boston 18
Kent 18
Medford 17
New York 17
Ann Arbor 14
Jakarta 14
Melbourne 12
Milan 12
San Diego 12
Paris 11
Salt Lake City 11
San Mateo 10
Abidjan 9
Mumbai 9
São Paulo 9
Boardman 8
Dong Ket 8
Clifton 7
Dallas 7
London 7
Rome 7
Turin 7
Bologna 6
Fontebuona 6
Johannesburg 6
Naples 6
Bengaluru 5
Chennai 5
Guangzhou 5
Hanoi 5
Lappeenranta 5
Malton 5
Nanjing 5
Orem 5
The Dalles 5
Thiene 5
Turku 5
Andover 4
Ardea 4
Elk Grove Village 4
Frankfurt am Main 4
Jacksonville 4
Medellín 4
Pontassieve 4
Poplar 4
Portland 4
Sterling 4
Tokyo 4
Toronto 4
Yubileyny 4
Bishkek 3
Cotonou 3
Curitiba 3
Davis 3
Denver 3
Goiânia 3
Ha Long 3
Helsinki 3
Hillsboro 3
Izmir 3
Lancaster 3
Laurel 3
Lucca 3
Ninh Bình 3
Norwalk 3
Phoenix 3
Pisa 3
Quito 3
St Petersburg 3
Wuhan 3
Acton 2
Totale 3.265
Nome #
Migraine-provoking substances evoke periorbital allodynia in mice 254
Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score 238
Protocol and methods for testing the efficacy of well-being therapy in chronic migraine patients: a randomized controlled trial 231
Transient receptor potential channels as novel drug targets in respiratory diseases. 220
Mental Pain Questionnaire: An item response theory analysis 200
TRPA1 and other TRP channels in migraine 196
Chronic headaches and medication overuse 181
Prophylactic activity of increasing doses of intravenous histamine in refractory migraine: Retrospective observations of a series of patients with migraine without aura 179
Low-dose methadone for refractory chronic migraine accompanied by medication-overuse headache: a prospective cohort study 166
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study 160
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: A post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial 156
Post onset, oral rapamycin treatment delays development of mitochondrial encephalopathy only at supramaximal doses 153
Criterion-related validity in a sample of migraine outpatients: The diagnostic criteria for psychosomatic research 150
Acute and chronic triptan exposure neither alters rodent cerebral blood flow nor worsens ischemic brain injury 150
Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ) 147
Self-administered subcutaneous diclofenac sodium in acute migraine attack: A randomized, double-blind, placebo-controlled dose-finding pilot study 143
Ultra-rapid brain uptake of subcutaneous sumatriptan in the rat: Implication for cluster headache treatment 136
Mental Pain Questionnaire: Clinimetric Properties of a Potential Global Person‐Centred Outcome Measure 134
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine 128
Migraine Models 125
Predictors of sustained response and effects of the discontinuation of anti-calcitonin gene related peptide antibodies and reinitiation in resistant chronic migraine 125
Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series 120
Mental pain and pain-proneness in migraine subjects: Results from the PAINMIG cohort-study 119
Epidemiology and determinants of chronic migraine: A real-world cohort study, with nested case-control analysis, in primary care in Italy 118
Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study From the Italian National Headache Registry (RICe) 114
Emerging Pharmacological Treatments for Migraine in the Pediatric Population 113
Migraine during covid-19: Data from second wave pandemic in an Italian cohort 112
The role of TRP ion channels in migraine and headache 111
COVID-19 pneumonia during long-term migraine prophylaxis with fremanezumab: a case report 105
Utilization patterns, cardiovascular risk, and concomitant serotoninergic medications among triptan users between 2008 and 2018: A gender analysis in one Italian region, Tuscany 104
Mental pain as a global person-centred outcome measure 100
Switching OnabotulinumtoxinA to Monoclonal Anti-CGRP Antibodies in Drug-Resistant Chronic Migraine 90
Multi-domain destructuring in the early phases of psychosis: a multicentric phenomenological and psychometric case-control study 80
Outcomes, unmet needs, and challenges in the management of patients who withdraw from anti-CGRP monoclonal antibodies: A prospective cohort study 71
Anti-CGRP monoclonal antibodies counteract establishment of food aversive memories and chemotherapy-induced anorexia and weight loss 12
Totale 4.941
Categoria #
all - tutte 14.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021182 0 0 0 0 0 52 10 23 27 36 11 23
2021/2022197 7 6 7 5 7 5 4 14 15 28 38 61
2022/2023576 45 124 39 15 16 81 66 22 55 17 28 68
2023/2024275 7 28 34 25 18 24 19 57 11 14 31 7
2024/20251.957 60 174 111 255 526 261 51 124 69 152 91 83
2025/20261.078 227 260 160 165 220 46 0 0 0 0 0 0
Totale 4.941